Acadian Asset Management
TRAW icon

Acadian Asset Management’s Traws Pharma TRAW Stock Holding History

Acadian Asset Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10
Closed -$8K – 2061
2018
Q4 		$8K Buy
+10
New +$17K ﹤0.01% 1626

Other funds holding TRAW

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management's TRAW Position: Q1 2019 in Review

Acadian Asset Management sold out of Traws Pharma (TRAW) in Q1 2019, closing a stake of 10 shares — an estimated $8K sold.

Acadian Asset Management first reported a position in TRAW in Q4 2018 and held it in 1 quarter. The position peaked at $8K in Q4 2018. 12 funds tracked by Wall St. Rank hold TRAW as of Q1 2019.

  • Acadian Asset Management reported no remaining Traws Pharma position as of Q1 2019 after selling out during the quarter.
  • Acadian Asset Management sold 10 Traws Pharma shares in Q1 2019, an estimated $8K.
  • Acadian Asset Management first reported a position in Traws Pharma in Q4 2018 and held it in 1 quarter.
  • Acadian Asset Management's Traws Pharma position peaked at $8K in Q4 2018.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2019.

Based on Acadian Asset Management's 13F filing for Q1 2019, filed 9 May 2019.